Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226
Heba F. Ashour, Laila Abou‐Zeid, Magda A.‐A. El‐Sayed, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112062-112062
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1909-1909
Open Access | Times Cited: 1180
1,2,3‐Triazole hybrids as anticancer agents: A review
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 205
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access | Times Cited: 1
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Osama M. Soltan, Mai E. Shoman, Salah A. Abdel‐Aziz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113768-113768
Closed Access | Times Cited: 85
Application of triazoles in the structural modification of natural products
Hongyan Guo, Chen Zheng-ai, Qing‐Kun Shen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1115-1144
Open Access | Times Cited: 70
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105762-105762
Closed Access | Times Cited: 51
The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
Deniz Lengerli, Kübra İbiş, Yahya Nural, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 11, pp. 1209-1236
Closed Access | Times Cited: 51
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 37
Recent Advances in the Green Synthesis of Active N-Heterocycles and Their Biological Activities
Suman Majee, Shilpa Shilpa, Mansi Sarav, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 873-873
Open Access | Times Cited: 23
Synthesis and Biological Evaluation of 1,2,3-Triazole Tethered Thymol-1,3,4-Oxadiazole Derivatives as Anticancer and Antimicrobial Agents
Abdulraheem S. A. Almalki, Syed Nazreen, Azizah M. Malebari, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 866-866
Open Access | Times Cited: 41
The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105968-105968
Closed Access | Times Cited: 31
Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 28
Recent advances in chalcone-triazole hybrids as potential pharmacological agents
Akanksha Bhukal, Vijay Kumar, Lokesh Kumar, et al.
Results in Chemistry (2023) Vol. 6, pp. 101173-101173
Open Access | Times Cited: 15
Design, synthesis and in silico molecular docking evaluation of novel 1,2,3-triazole derivatives as potent antimicrobial agents
Sudhakar Reddy Baddam, Mahesh Kumar Avula, Raghunadh Akula, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e27773-e27773
Open Access | Times Cited: 6
Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy
Mohamed S. Nafie, M. Ali, Moayad Abdullah Alwehaibi, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 58-74
Open Access
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
Design and Synthesis of New Quinazolinone Derivatives Conjugated with Chalcone or Pyridazine Moieties: Anticancer Activities and Apoptotic Induction
Dina S. M. Elazab, Dina I. A. Othman, Khalid B. Selim, et al.
Polycyclic aromatic compounds (2025), pp. 1-24
Closed Access
A minireview of 1,2,3‐triazole hybrids with O‐heterocycles as leads in medicinal chemistry
Bhavna Saroha, Gourav Kumar, Ramesh Kumar, et al.
Chemical Biology & Drug Design (2021) Vol. 100, Iss. 6, pp. 843-869
Closed Access | Times Cited: 38
Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives
Bathélémy Ngameni, Kamdoum Cedric, Armelle T. Mbaveng, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 35, pp. 127827-127827
Closed Access | Times Cited: 33
1,2,3-Triazole Derivatives with Anti-breast Cancer Potential
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 22
Synthesis and biological evaluation of ciprofloxacin – 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents
Samir Al-Taweel, Yousef M. Al-saraireh, Salah A. Al‐Trawneh, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22592-e22592
Open Access | Times Cited: 14
Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma
Mostafa A. Mansour, Asmaa M. AboulMagd, Samar H. Abbas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 4
The metal sensing applications of chalcones: The synthesis, characterization and theoretical calculations
Hüseyin Karaca, Sözcan Kazancı
Journal of Molecular Structure (2021) Vol. 1248, pp. 131454-131454
Closed Access | Times Cited: 28
Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies
Aynur Çot, Mustafa Çeşme, Sultan Onur, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6857-6865
Closed Access | Times Cited: 20
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top